Prevention of NAFLD and CVD Through Lifestyle Intervention
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-60
SponsorPontificia Universidad Catolica de Chile
About this trial
Prevention of non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) through lifestyle intervention (MAUCO+) is a clinical trial that aims to improve sarcopenia, aerobic capacity, body composition, and lipid profile, insulin resistance, cardiovascular risk, NAFLD, and maintain a healthier lifestyle. Through the implementation of physical activity and nutritional programs.
Eligibility criteria
Qualifiers
With and without gallstones disease
With various degrees of NAFLD (none too severe)
Disqualifiers
Any significant comorbidity or physical limitation to undergo resistance exercise program
Use of medications that alter muscle mass (e.g., corticosteroids)
History of hepatitis B or C
Use of hepatotoxic drugs
Trial design
Treatments tested in this trial
- Physical exercise and dietary intervention for NAFLD
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov